Brainsway - ADR opened lower at $10.71, compared with its previous close of $11.24. In the last trading session, the stock traded between $10.20 and $10.95. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Brainsway - ADR is now worth
$ 257.70
Giving a profit of
$ 157.70 (157.70%)
Note: Past profits do not guarantee future returns.
Rating from 2 Analysts
Today's Change
$-0.95 (-8.41%)
Day High
$10.95
Day Low
$10.20
Day Open
$10.71
Prev Close
$11.24
Volume
1,90,313
1W Return
-8.08%
1M Return
-10.09%
3M Return
-31.04%
6M Return
-38.46%
1Y Return
35.64%
Market Cap ($ Mn)
414
PE Ratio
62.17
PB Ratio
7.49
PEG Ratio
0.40
ROE
12.14%
ROCE
6.18%
EPS (TTM)
$0.07
1 Week
-8.08%
1 Month
-10.09%
3 Months
-31.04%
6 Months
-38.46%
9 Months
-12.12%
BrainsWay signs strategic collaboration with Inland Psychiatry Medical Group
BrainsWay signs strategic collaboration with Inland Psychiatric Medical Group. Multi-system Deep TMS deployment planned across Southern California clinics. Partnership includes exploration of scientific and clinical research projects. IPMG serves patients in Riverside, San Bernardino, Los Angeles, and Orange Counties.
24 days agoBrainsWay Deep TMS Study Shows 70% Reduction in Suicidal Ideation
Suicidal ideation signs dropped from 22.5% to 6.7% after six weeks of Deep TMS treatment. SWIFT protocol showed median improvement time of 10 days versus 13 days for standard protocol. Study analyzed 89 MDD patients from a prior trial that led to September 2025 FDA clearance. Results support broader 2026 research linking TMS to reduced suicidal ideation intensity.
2mo agoBrainsWay to report Q2 2026 results on August 12
BrainsWay Ltd. will announce Q2 2026 financial results on August 12, 2026, before U.S. market open. A conference call at 8:30 AM ET will cover operational highlights and business updates. Hebrew-language coverage follows on August 13.
3mo agoBrainsWay invests $3 million in Radial Health Series A
BrainsWay Ltd. has invested $3 million in Radial Health, Inc. as part of its Series A financing round, joining investors like General Catalyst. The capital will support Radial's M&A exploration and clinical footprint expansion, aligning with BrainsWay's strategy to increase access to Deep TMS technology.
3mo agoBTIG initiates coverage on BrainsWay with Buy rating, $18 target
BTIG analyst Sam Eiber has initiated coverage on BrainsWay with a Buy rating and a price target of $18. The stock is listed on NASDAQ under the ticker BWAY.
3mo agoBrainsWay invests $500,000 for minority stake in Sound Minds Behavioral
BrainsWay Ltd. invested $500,000 for a minority position in Sound Minds Behavioral, a growth-oriented outpatient behavioral health platform, via a preferred, annually compounding security. The strategic equity financing round supports operations across Connecticut, Pennsylvania, New Jersey, and New York, aiming to expand access to interventional psychiatry solutions.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $109.29 | -1.06% | $1,89,283.94M | 36.28 | |
| $449.53 | -0.11% | $1,55,826.88M | 42.73 | |
| $101.61 | +0.02% | $1,29,976.46M | 24.46 | |
| $318.79 | -1.70% | $1,21,360.48M | 34.27 | |
| $45.13 | +0.96% | $65,414.72M | 18.96 | |
| $105.81 | +1.73% | $60,840.75M | 53.70 | |
| $214.52 | +0.90% | $58,432.46M | 44.07 | |
| $82.60 | -1.26% | $37,346.60M | 16.49 | |
| $42.16 | +3.06% | $37,044.18M | 89.05 | |
| $72.46 | -2.16% | $35,027.16M | 54.55 | |
| $237.20 | +1.61% | $33,458.08M | 23.04 | |
| $80.35 | +0.53% | $29,964.75M | 36.04 |
An investment of $100 made 5 years ago in Brainsway - ADR is now worth
$ 257.70
Giving a profit of
$ 157.70 (157.70%)
Note: Past profits do not guarantee future returns.
